Literature DB >> 28145612

Coronary artery perforations after contemporary percutaneous coronary interventions: Evaluation of incidence, risk factors, outcomes, and predictors of mortality.

Jessica Parsh1, Milan Seth1, Jacqueline Green1, Nadia R Sutton1, Stanley Chetcuti1, Simon Dixon2, Paul M Grossman1, Akshay Khandelwal3, James M Dupree4, Hitinder S Gurm1,5.   

Abstract

OBJECTIVES: We sought to evaluate the incidence, risk factors, in-hospital, and long-term outcomes and predictors of mortality of coronary artery perforations (CAP) in the contemporary percutaneous coronary intervention (PCI) era.
BACKGROUND: CAP is a rare but serious complication of PCI associated with increased risk of morbidity and mortality.
METHODS: We included 181,590 procedures performed across 47 hospitals in Michigan from January 1, 2010 to December 31, 2015. Endpoints evaluated included the incidence of CAP and its association with in-hospital outcomes. Logistic regression analysis was utilized to determine independent risk factors for CAP and to examine whether the effect of CAP on mortality varied by gender.
RESULTS: CAP occurred in 625 (0.34%) patients. Independent predictors for CAP included older age, peripheral arterial disease, presence of left ventricular dysfunction or cardiomyopathy, lower body mass index, pre-PCI insertion of a mechanical ventricular support device, treatment of complex lesions (Type C), and treatment of chronic total occlusions, the latter of which was the strongest predictor of perforation (adjusted odds ratio (OR) 7.01, P < 0.001). After adjusting for baseline risk, the incidence of adverse outcomes remained substantially greater in patients with a perforation, with an adjusted OR estimate of 5.00 for mortality (95% CI 3.42-7.31), 3.25 for acute kidney injury (95% CI 2.30-4.58), and 5.26 for transfusion (95% CI 4.03-6.87) (all P < 0.001). Perforation was associated with a higher mortality in women than men (interaction P value = 0.01).
CONCLUSIONS: CAP is a rare complication but is associated with high morbidity and mortality especially in women. Further investigation is warranted to determine why women fare worse after CAP.
© 2017 Wiley Periodicals, Inc. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  coronary aneurysm/dissection/perforation; gender; health care outcomes; outcomes/studies

Mesh:

Year:  2017        PMID: 28145612     DOI: 10.1002/ccd.26917

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  5 in total

1.  Efficacy and Biosafety of a New Bioresorbable Vascular Scaffold Covered with Biodegradable Film in Rabbits: An In Vivo Study.

Authors:  Wei Cai; En Chen; Xiaoling Zeng; Canqiang Chen; Lingzhen Wu; Xingchun Zheng; Lianglong Chen
Journal:  Acta Cardiol Sin       Date:  2020-11       Impact factor: 2.672

2.  Early and Long-Term Outcomes in Patients Undergoing Cardiac Surgery Following Iatrogenic Injuries During Percutaneous Coronary Intervention.

Authors:  Alexander Verevkin; Konstantin von Aspern; Sergey Leontyev; Sven Lehmann; Michael A Borger; Piroze M Davierwala
Journal:  J Am Heart Assoc       Date:  2019-01-08       Impact factor: 5.501

3.  Emergency Surgery for Iatrogenic Injuries attributable to Percutaneous Coronary Interventions: When Planning and Time Matter.

Authors:  Alessandro Affronti; Marc Ruel
Journal:  J Am Heart Assoc       Date:  2019-01-08       Impact factor: 5.501

4.  Five-year report from the Polish national registry on percutaneous coronary interventions with a focus on coronary artery perforations within chronic total occlusions.

Authors:  Rafał Januszek; Leszek Bryniarski; Zbigniew Siudak; Krzysztof P Malinowski; Krzysztof L Bryniarski; Andrzej Surdacki; Artur Dziewierz; Piotr Mika; Wojciech Wańha; Wojciech Wojakowski; Jarosław Wójcik; Jacek Legutko; Stanisław Bartuś
Journal:  Postepy Kardiol Interwencyjnej       Date:  2020-12-29       Impact factor: 1.426

5.  Novel Approaches to Coronary Perforations: Everything But the Kitchen Sink.

Authors:  Dany Jacob; Michael P Savage; David L Fischman
Journal:  JACC Case Rep       Date:  2022-02-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.